Scientists developed a process (or pipeline) that combined molecular probes—a specific chemical that binds to microbes carrying out a particular function—with a method that isolated these cells from their complex community.
Scientists screen for nanobodies that recognize wild type and mutant functional proteins to develop a framework to disrupt protein interactions that can cause disease.
Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.